The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV N Manel, FJ Kim, S Kinet, N Taylor, M Sitbon, JL Battini Cell 115 (4), 449-459, 2003 | 588 | 2003 |
Glutamine-dependent α-ketoglutarate production regulates the balance between T helper 1 cell and regulatory T cell generation D Klysz, X Tai, PA Robert, M Craveiro, G Cretenet, L Oburoglu, ... Science signaling 8 (396), ra97-ra97, 2015 | 480 | 2015 |
Glucose and glutamine metabolism regulate human hematopoietic stem cell lineage specification L Oburoglu, S Tardito, V Fritz, SC De Barros, P Merida, M Craveiro, ... Cell stem cell 15 (2), 169-184, 2014 | 301 | 2014 |
Erythrocyte Glut1 triggers dehydroascorbic acid uptake in mammals unable to synthesize vitamin C A Montel-Hagen, S Kinet, N Manel, C Mongellaz, R Prohaska, JL Battini, ... Cell 132 (6), 1039-1048, 2008 | 281 | 2008 |
Antagonistic properties of human prolactin analogs that show paradoxical agonistic activity in the Nb2 bioassay V Goffin, S Kinet, F Ferrag, N Binart, JA Martial, PA Kelly Journal of Biological Chemistry 271 (28), 16573-16579, 1996 | 153 | 1996 |
Glut1-mediated glucose transport regulates HIV infection S Loisel-Meyer, L Swainson, M Craveiro, L Oburoglu, C Mongellaz, ... Proceedings of the National Academy of Sciences 109 (7), 2549-2554, 2012 | 150 | 2012 |
Homeostasis of naive and memory CD4+ T cells: IL-2 and IL-7 differentially regulate the balance between proliferation and Fas-mediated apoptosis S Jaleco, L Swainson, V Dardalhon, M Burjanadze, S Kinet, N Taylor The Journal of Immunology 171 (1), 61-68, 2003 | 149 | 2003 |
IL-7–induced proliferation of recent thymic emigrants requires activation of the PI3K pathway L Swainson, S Kinet, C Mongellaz, M Sourisseau, T Henriques, N Taylor Blood 109 (3), 1034-1042, 2007 | 140 | 2007 |
Solution structure of human prolactin K Teilum, JC Hoch, V Goffin, S Kinet, JA Martial, BB Kragelund Journal of molecular biology 351 (4), 810-823, 2005 | 135 | 2005 |
IL-7 differentially regulates cell cycle progression and HIV-1-based vector infection in neonatal and adult CD4+ T cells V Dardalhon, S Jaleco, S Kinet, B Herpers, M Steinberg, C Ferrand, ... Proceedings of the National Academy of Sciences 98 (16), 9277-9282, 2001 | 127 | 2001 |
Cell surface Glut1 levels distinguish human CD4 and CD8 T lymphocyte subsets with distinct effector functions G Cretenet, I Clerc, M Matias, S Loisel, M Craveiro, L Oburoglu, S Kinet, ... Scientific reports 6 (1), 24129, 2016 | 107 | 2016 |
Glucose transporter 1 expression identifies a population of cycling CD4+CD8+ human thymocytes with high CXCR4-induced chemotaxis L Swainson, S Kinet, N Manel, JL Battini, M Sitbon, N Taylor Proceedings of the national academy of sciences 102 (36), 12867-12872, 2005 | 102 | 2005 |
The HTLV receptor is an early T-cell activation marker whose expression requires de novo protein synthesis N Manel, S Kinet, JL Battini, FJ Kim, N Taylor, M Sitbon Blood, The Journal of the American Society of Hematology 101 (5), 1913-1918, 2003 | 97 | 2003 |
Evidence for a second receptor binding site on human prolactin. V Goffin, I Struman, V Mainfroid, S Kinet, JA Martial Journal of Biological Chemistry 269 (51), 32598-32606, 1994 | 92 | 1994 |
Metabolic regulation of hematopoietic stem cell commitment and erythroid differentiation L Oburoglu, M Romano, N Taylor, S Kinet Current Opinion in Hematology 23 (3), 198-205, 2016 | 90 | 2016 |
Growth hormone (GH) and prolactin receptors in human peripheral blood mononuclear cells: relation with age and GH-binding protein JL Bresson, S Jeay, MC Gagnerault, C Kayser, N Beressi, Z Wu, S Kinet, ... Endocrinology 140 (7), 3203-3209, 1999 | 87 | 1999 |
GLUT1 protects prostate cancer cells from glucose deprivation-induced oxidative stress P Gonzalez-Menendez, D Hevia, R Alonso-Arias, A Alvarez-Artime, ... Redox biology 17, 112-127, 2018 | 84 | 2018 |
Isolated receptor binding domains of HTLV-1 and HTLV-2 envelopes bind Glut-1 on activated CD4+ and CD8+ T cells S Kinet, L Swainson, M Lavanya, C Mongellaz, A Montel-Hagen, ... Retrovirology 4, 1-9, 2007 | 80 | 2007 |
S179D-human PRL, a pseudophosphorylated human PRL analog, is an agonist and not an antagonist S Bernichtein, S Kinet, S Jeay, M Llovera, D Madern, JA Martial, PA Kelly, ... Endocrinology 142 (9), 3950-3963, 2001 | 70 | 2001 |
Developmental differences between neonatal and adult human erythropoiesis H Yan, J Hale, J Jaffray, J Li, Y Wang, Y Huang, X An, C Hillyer, N Wang, ... American journal of hematology 93 (4), 494-503, 2018 | 64 | 2018 |